110 related articles for article (PubMed ID: 3791237)
1. Morphological study of the combined effect of purpurin derivatives and light on transplantable rat bladder tumors.
Morgan AR; Garbo GM; Kreimer-Birnbaum M; Keck RW; Chaudhuri K; Selman SH
Cancer Res; 1987 Jan; 47(2):496-8. PubMed ID: 3791237
[TBL] [Abstract][Full Text] [Related]
2. New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors.
Morgan AR; Garbo GM; Keck RW; Selman SH
Cancer Res; 1988 Jan; 48(1):194-8. PubMed ID: 3334995
[TBL] [Abstract][Full Text] [Related]
3. A dose response analysis of purpurin derivatives used as photosensitizers for the photodynamic treatment of transplantable FANFT induced urothelial tumors.
Selman SH; Garbo GM; Keck RW; Kreimer-Birnbaum M; Morgan AR
J Urol; 1987 Jun; 137(6):1255-7. PubMed ID: 3586170
[TBL] [Abstract][Full Text] [Related]
4. Metallopurpurins and light: effect on transplantable rat bladder tumors and murine skin.
Morgan AR; Garbo GM; Keck RW; Eriksen LD; Selman SH
Photochem Photobiol; 1990 May; 51(5):589-92. PubMed ID: 2142308
[TBL] [Abstract][Full Text] [Related]
5. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light.
Selman SH; Kreimer-Birnbaum M; Klaunig JE; Goldblatt PJ; Keck RW; Britton SL
Cancer Res; 1984 May; 44(5):1924-7. PubMed ID: 6231988
[TBL] [Abstract][Full Text] [Related]
6. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
7. New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effect on normal tissue.
Morgan AR; Rampersaud A; Garbo GM; Keck RW; Selman SH
J Med Chem; 1989 Apr; 32(4):904-8. PubMed ID: 2704035
[TBL] [Abstract][Full Text] [Related]
8. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo.
Bellnier DA; Prout GR; Lin CW
J Natl Cancer Inst; 1985 Mar; 74(3):617-25. PubMed ID: 3856065
[TBL] [Abstract][Full Text] [Related]
9. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
[TBL] [Abstract][Full Text] [Related]
11. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
12. Treatment of the transplantable FANFT induced bladder tumors with the purpurin SnET2 and red light emitted by a pulsed frequency doubled Nd:YAG laser.
Selman SH; Fitkin DL; Keck RW; Morgan AR; Doiron DR
J Laser Appl; 1991; 3(2):45-8. PubMed ID: 10149393
[TBL] [Abstract][Full Text] [Related]
13. [Photochemotherapy of experimental tumors in animals using various photosensitizers].
König K; Bockhorn V; Dietel W; Schubert H
Z Urol Nephrol; 1989 Nov; 82(11):601-7. PubMed ID: 2618185
[TBL] [Abstract][Full Text] [Related]
14. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid.
Stocker S; Knüchel R; Sroka R; Kriegmair M; Steinbach P; Baumgartner R
J Urol; 1997 Jan; 157(1):357-61. PubMed ID: 8976297
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic effects of sulfonated aluminum chlorophthalocyanine in human urinary bladder carcinoma cells in vitro.
Müller M; Reich E; Steiner U; Heicappell R; Miller K
Eur Urol; 1997; 32(3):339-43. PubMed ID: 9358224
[TBL] [Abstract][Full Text] [Related]
16. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study.
Ibrahiem EH; Nigam VN; Brailovsky CA; Madarnas P; Elhilali M
Cancer Res; 1983 Feb; 43(2):617-22. PubMed ID: 6848183
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic treatment of transplantable bladder tumors in rodents after pretreatment with chloroaluminum tetrasulfophthalocyanine.
Selman SH; Kreimer-Birnbaum M; Chaudhuri K; Garbo GM; Seaman DA; Keck RW; Ben-Hur E; Rosenthal I
J Urol; 1986 Jul; 136(1):141-5. PubMed ID: 3712601
[TBL] [Abstract][Full Text] [Related]
18. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
Daskal Y; Soloway MS; DeFuria MD; Crooke ST
Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
[TBL] [Abstract][Full Text] [Related]
19. [Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
Vlasov NN; Pliss GB; Balin VV
Vopr Onkol; 1980; 26(3):63-7. PubMed ID: 7368659
[TBL] [Abstract][Full Text] [Related]
20. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
Grossman HB; Sonda LP; Lesser ML
Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
